The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials.

@article{LpezHuertas2012TheEO,
  title={The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials.},
  author={Eduardo L{\'o}pez-Huertas},
  journal={The British journal of nutrition},
  year={2012},
  volume={107 Suppl 2},
  pages={S185-94}
}
Metabolic syndrome (MS) is characterised by accumulation of CVD risk factors. The use of very long chain n-3 polyunsaturated fatty acids (VLC n3 PUFA) could potentially benefit MS by reducing risk factors. To better understand the possible VLC n3 PUFA benefits, the literature was systematically reviewed for randomised controlled trials (RCT) that published effects of VLC n3 PUFA on MS patients. 17 RCT fulfilled the inclusion criteria and were analysed for relevance to the research question. The… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
23 Citations
75 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 75 references

Similar Papers

Loading similar papers…